These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 409782)

  • 21. [Stimulation of the secretory IgA system in monkeys by parenteral immunization with a ribosomal Sonne dysentery vaccine].
    Dzhikidze EK; Stasilevich ZK; Salamatova SA
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Sep; (9):66-70. PubMed ID: 2462772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The mouse paw edema test for titrating Shigella toxin and antitoxin and for determining the safety of the anatoxin].
    Kamzolkina NB; Volkov AV
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Jul; (7):68-70. PubMed ID: 3314277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune processes in the course of infection with dysentery bacilli. III. Protective activity of spleen cells and serum from mice immunized with killed dysentery bacilli.
    Kowalewska D; Wieczorek Z
    Arch Immunol Ther Exp (Warsz); 1977; 25(1):69-78. PubMed ID: 327970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Safety and immunologic effectiveness of polyantigen from shigellae for oral immunization of monkeys].
    Dzhikidze EK; Kavtaradze KN; Raush K; Ketii I; Krasnoproshina LI
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Nov; (11):73-8. PubMed ID: 413291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein conjugates of synthetic saccharides elicit higher levels of serum IgG lipopolysaccharide antibodies in mice than do those of the O-specific polysaccharide from Shigella dysenteriae type 1.
    Pozsgay V; Chu C; Pannell L; Wolfe J; Robbins JB; Schneerson R
    Proc Natl Acad Sci U S A; 1999 Apr; 96(9):5194-7. PubMed ID: 10220442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Shigellosis and Escherichia coli diarrhea: relative importance of invasive and toxigenic mechanisms.
    O'Brien AD; Gentry MK; Thompson MR; Doctor BP; Gemski P; Formal SB
    Am J Clin Nutr; 1979 Jan; 32(1):229-33. PubMed ID: 104615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adoptive transfer of immunity to dysentery bacilli with immune T lymphocytes from mice orally immunized with Shigella sonnei bacilli.
    Kowalewska D; Wieczorek Z
    Arch Immunol Ther Exp (Warsz); 1980; 28(4):593-601. PubMed ID: 7006564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potentials of Shigella flexneri Y strain TSF21 as a candidate vaccine against shigellosis: safety, immunogenicity and protective efficacy in Bonnet monkeys.
    Ashraf MM; Giri DK; Batra HV; Khandekar P; Ahmed ZU; Talwar GP
    FEMS Microbiol Immunol; 1991 Jun; 3(3):165-70. PubMed ID: 1878259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histological changes in the central nervous system produced by dysentery bacilli (Shigella dysenteriae). II. Experiments in monkeys (Macacus cyclopis).
    KISHIDA T
    Yokohama Med Bull; 1953 Apr; 4(2):61-8. PubMed ID: 13103146
    [No Abstract]   [Full Text] [Related]  

  • 30. Antibody response to lipopolysaccharide antigen in Shigella dysenteriae type 1 infection.
    Sinha AK; Bhattacharya SK; Saha MR; Bhattacharya MK; Sen D; Ghosh AC; Pal SC
    Indian J Med Res; 1988 Jul; 88():1-6. PubMed ID: 3053437
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of intravenous and aerosol administration of crude Shigella toxin to rhesus macaques: preliminary study.
    Liu CT; Sanders RP; Dominik JW; Formal SB
    Am J Vet Res; 1980 May; 41(5):836-9. PubMed ID: 6773452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Shigellosis control--a rosy future?
    Kevsch GT
    J Infect Dis; 1977 Sep; 136(3):456-7. PubMed ID: 333037
    [No Abstract]   [Full Text] [Related]  

  • 33. Studies with Shigella dysenteriae (Shiga) infection and intoxication in Macacus mulatta monkeys.
    BRANHAM SE; HABEL K; LILLIE RD
    J Infect Dis; 1949; 85(3):295-303. PubMed ID: 15392992
    [No Abstract]   [Full Text] [Related]  

  • 34. Shigella-specific IgA in saliva of children with bacillary dysentery.
    Schultsz C; Qadri F; Hossain SA; Ahmed F; Ciznar I
    FEMS Microbiol Immunol; 1992 Jan; 4(2):65-72. PubMed ID: 1547024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mucosal immune response in patients with dysentery.
    Ciznar I; Qadri F; Hoque S; Bin AA; Schultsz C; Bartkova G
    Adv Exp Med Biol; 1995; 371B():919-22. PubMed ID: 7502926
    [No Abstract]   [Full Text] [Related]  

  • 36. Assembly, Biochemical Characterization, Immunogenicity, Adjuvanticity, and Efficacy of
    Turbyfill KR; Clarkson KA; Vortherms AR; Oaks EV; Kaminski RW
    mSphere; 2018; 3(2):. PubMed ID: 29600284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of recombinant vaccine candidate molecule against Shigella infection.
    Chitradevi STS; Kaur G; Sivaramakrishna U; Singh D; Bansal A
    Vaccine; 2016 Oct; 34(44):5376-5383. PubMed ID: 27591952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New trends in the use of Al(OH)3-conjugated endotoxins and their subunits from the S- and R-forms of Shigella dysenteriae serovar 1 for model vaccination purposes.
    Sourek J; Levin J; Trnka T; Zelenková L
    Vaccine; 1991 Feb; 9(2):106-10. PubMed ID: 1905447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Failure of parenteral vaccines to protect monkeys against experimental shigellosis.
    Formal SB; Maenza RM; Austin S; LaBrec EH
    Proc Soc Exp Biol Med; 1967 Jun; 125(2):347-9. PubMed ID: 4961488
    [No Abstract]   [Full Text] [Related]  

  • 40. Shigella outer membrane protein PSSP-1 is broadly protective against Shigella infection.
    Kim JO; Rho S; Kim SH; Kim H; Song HJ; Kim EJ; Kim RY; Kim EH; Sinha A; Dey A; Yang JS; Song MK; Nandy RK; Czerkinsky C; Kim DW
    Clin Vaccine Immunol; 2015 Apr; 22(4):381-8. PubMed ID: 25651919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.